Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Stacy L. Moulder"'
Autor:
Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S Sonke, Tessa G Steenbruggen, Maartje van Seijen, Jelle Wesseling, Miguel Martín, Maria del Monte-Millán, Sara López-Tarruella, Judy C Boughey, Matthew P Goetz, Tanya Hoskin, Rebekah Gould, Vicente Valero, Stephen B Edge, Jean E Abraham, John M S Bartlett, Carlos Caldas, Janet Dunn, Helena Earl, Larry Hayward, Louise Hiller, Elena Provenzano, Stephen-John Sammut, Jeremy S Thomas, David Cameron, Ashley Graham, Peter Hall, Lorna Mackintosh, Fang Fan, Andrew K Godwin, Kelsey Schwensen, Priyanka Sharma, Angela M DeMichele, Kimberly Cole, Lajos Pusztai, Mi-Ok Kim, Laura J van 't Veer, Laura J Esserman, W Fraser Symmans, Kathi Adamson, Kathy S. Albain, Adam L. Asare, Smita M. Asare, Ron Balassanian, Heather Beckwith, Scott M. Berry, Donald A. Berry, Judy C. Boughey, Meredith B. Buxton, Yunn-Yi Chen, Beiyun Chen, A. Jo Chien, Stephen Y. Chui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Angela M. DeMichele, Xiuzhen Duan, Kirsten K. Edmiston, Anthony D. Elias, Erin D. Ellis, Laura L. Esserman, David M. Euhus, Oluwole Fadare, Michael D Feldman, Andres Forero-Torres, Barbara B. Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly E. Klein, Gregor Krings, Julie E. Lang, Lauren G. LeBeau, Brian Leyland-Jones, Minetta C. Liu, Shelly Lo, Janice Lu, Anthony Magliocco, Jeffrey B. Matthews, Michelle E. Melisko, Paulette Mhawech-Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris T. Ocal, Olufunmilayo Olopade, Stefan Pambuccian, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Garry Peterson, Mara Rendi, Hope S. Rugo, Sunati Sahoo, Sharon Sams, Ashish Sanil, Husain Sattar, Richard B. Schwab, Ruby Singhrao, Katherine Steeg, Erica Stringer-Reasor, W. Fraser Symmans, Ossama Tawfik, Debasish Tripathy, Megan L. Troxell, Laura J. van't Veer, Sara J. Venters, Tuyethoa Vinh, Rebecca K. Viscusi, Anne M. Wallace, Shi Wei, Amy Wilson, Douglas Yee, Jay C. Zeck
Publikováno v:
I-SPY 2 Trial Consortium 2022, ' Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multicentre pooled analysis of 5161 patients ', The Lancet Oncology, vol. 23, no. 1, pp. 149-160 . https://doi.org/10.1016/S1470-2045(21)00589-1
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
Background: Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis to evaluate the rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b5a03d8d05046179f5dcc364471bd0
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
Autor:
Funda Meric-Bernstam, Rosalind P. Candelaria, Jennifer K. Litton, Gaiane M. Rauch, Beatriz E. Adrada, Colleen T. Eppig, Debu Tripathy, Kenneth R. Hess, Senthil Damodaran, Stacy L. Moulder, Bora Lim, Krzysztof J. Grzegorzewski, Ignacio I. Wistuba, Jason B White
Publikováno v:
Cancer Research. 80:OT2-06
Background:While TNBC patients with pathologic complete response (pCR) or residual cancer burden (RCB-I) have good survival rates, those with extensive residual disease (RCB-II or RCB-III) after neoadjuvant chemotherapy (NACT) have poor prognosis. Pa
Autor:
Abenaa M. Brewster, Rashmi Krishna Murthy, Alastair M. Thompson, Nuhad K. Ibrahim, Vicente Valero, Sarah M. DeSnyder, Senthil Damodaran, Helen Piwnica-Worms, Stacy L. Moulder, Gary J. Whitman, Thorunn Helgason, Jennifer K. Litton, Beatriz E. Adrada, Jill Schwartz-Gomez, Kenneth R. Hess, Carlos H. Barcenas, Banu Arun, Elizabeth A. Mittendorf, Marion E. Scoggins
Publikováno v:
J Clin Oncol
PURPOSE Talazoparib has demonstrated efficacy in patients with BRCA-positive metastatic breast cancer. This study evaluated the pathologic response of talazoparib alone for 6 months in patients with a known germline BRCA pathogenic variant (g BRCA-po
Autor:
Gordon Broderick, Eileen H. Shinn, Bryan Fellman, Ainslee Johnson, Elizabeth Wieland, William Fraser Symmans, Stacy L. Moulder
Publikováno v:
JCO Clinical Cancer Informatics
PURPOSE Nearly 40% of patients with breast cancer discontinue their adjuvant oral endocrine treatment (ET). We measured discontinuation rates of ET at a comprehensive cancer center. We then used an iterative approach to model patterns of determinants
Autor:
Michael Z. Gilcrease, Jinxia Zhang, Hua Guo, Hui Chen, Wei Lien Wang, Yun Gong, Erika Resetkova, Dawen Sui, Qingqing Ding, Stacy L. Moulder, Jun Zhao, Hui Liu, Yun Wu, Lei Huo, Min Zhao
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 22, Iss 1, Pp 1-18 (2020)
Breast Cancer Research, Vol 22, Iss 1, Pp 1-18 (2020)
Background In the evaluation of PD-L1 expression to select patients for anti-PD-1/PD-L1 treatment, uniform guidelines that account for different immunohistochemistry assays, different cell types and different cutoff values across tumor types are lack
Publikováno v:
American Society of Clinical Oncology Educational Book. :65-77
Metastatic breast cancer continues to be a life-threatening diagnosis that impacts hundreds of thousands of patients around the world. Targeted therapies are usually associated with less toxicity compared with cytotoxic chemotherapies and often induc
Autor:
Katherine Clifton, Gabriel N. Hortobagyi, Jennifer K. Litton, Henry Mark Kuerer, Constance Albarracin, Stacy L. Moulder, Banu Arun, Angelica M. Gutierrez-Barrera, Junsheng Ma, Roland L. Bassett
Publikováno v:
Breast Cancer Research and Treatment. 170:101-109
PURPOSE: As triple-negative breast cancers are associated with earlier recurrences and poorer survival, optimal treatment of early-stage breast cancer is essential. Several retrospective studies in triple-negative breast cancer have reported conflict
Autor:
Robert R. Jenq, Lei Huo, Bora Lim, Alastair M. Thompson, Naoto T. Ueno, Gabriel N. Hortobagyi, Elizabeth Ravenberg, Rashmi Krishna Murthy, Banu Arun, Chia-Chi Chang, Elizabeth A. Mittendorf, Clinton Yam, Debu Tripathy, Jennifer K. Litton, Senthil Damodaran, Stacy L. Moulder, Nuhad K. Ibrahim, Vicente Valero, Nour Abuhadra, Jason B White
Publikováno v:
Journal of Clinical Oncology. 39:590-590
590 Background: The impact of gut microbiome on tumor biology, progression and response to immunotherapy has been shown across cancer types. However, there is little known about the impact of gut microbial composition on response to chemotherapy. We
Autor:
Angela L. Harris, Timothy P. Heffernan, Prabhjot Mundi, Shirong Cai, Sabrina Jeter-Jones, Joseph R. Marszalek, Gloria V. Echeverria, Alessandro Carugo, Sahil Seth, Xiaoyan Ma, Xinhui Zhou, Huan Qiu, Yun Wu, Andrea Califano, Jeffrey T. Chang, Michael Peoples, Yizheng Tu, Yuting Sun, Mariano J. Alvarez, Stacy L. Moulder, Zhongqi Ge, Xiaomei Zhang, Jiansu Shao, Vandhana Ramamoorthy, Helen Piwnica-Worms, Aaron McCoy, Qing Chang, Christopher A. Bristow, Rosanna Lau, William Fraser Symmans
Eradicating triple negative breast cancer (TNBC) resistant to neoadjuvant chemotherapy (NACT) is a critical unmet clinical need. In this study, patient-derived xenograft (PDX) models of treatment-naïve TNBC and serial biopsies from TNBC patients und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db1b6fdb5fb8c374ed6a03be6865f479
https://europepmc.org/articles/PMC6541393/
https://europepmc.org/articles/PMC6541393/
Autor:
Vicente Valero, Bora Lim, Lei Huo, Ryan Sun, Alastair M. Thompson, Aysegul A. Sahin, Nuhad K. Ibrahim, Elizabeth Ravenberg, Clinton Yam, Rashmi Krishna Murthy, Elizabeth A. Mittendorf, Stacy L. Moulder, Banu Arun, Jason B White, Debu Tripathy, Senthil Damodaran, Beatriz E. Adrada, Anthony Lucci, Nour Abuhadra, Naoto T. Ueno, Jennifer K. Litton, Jeffrey T. Chang, Gabriel N. Hortobagyi
Publikováno v:
Cancer Research. 81:PS18-04
Background: MpBC is a rare breast cancer subtype that is commonly triple-negative and associated with a diminished response to NAT in published retrospective data sets, prompting some clinicians to recommend surgical resection followed by adjuvant th